Hargreaves Lansdown

Celadon Pharmaceuticals finance chief to step down

Mon 30 September 2024 11:08 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - Celadon Pharmaceuticals announced on Monday that Jonathan Turner, its chief financial officer, was stepping down.

The AIM-traded firm said Turner would vacate from his position on the board on 27 December.

It said it was starting the search for Turner's successor immediately, with an update to be provided once a new CFO had been appointed.

At 1507 BST, shares in Celadon Pharmaceuticals were down 20.55% at 29p.

Reporting by Josh White for Sharecast.com.

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More AIM news from ShareCast

    No results were found